FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Biologics

ImmunityBio Refiles Bladder Cancer BLA

ImmunityBio refiles its BLA for Anktiva (N-803) in combination with Bacillus Calmette-Gurin (BCG) for treating patients with BCG-unresponsive non-musc...

latest-news-card-1
Human Drugs

Keytruda Positive Data in Cervical Cancer

Merck says its Keytruda (pembrolizumab) plus concurrent chemoradiotherapy reduced the risk of disease progression or death by 30% compared to concurre...

latest-news-card-1
Federal Register

Guide on Drug Benefit-Risk Assessments

Federal Register notice: FDA makes available a final guidance entitled Benefit-Risk Assessment for Human Drug and Biological Products.

Medical Devices

Enhanced Coronary Lithotripsy Catheter OKd

FDA approves a Shockwave Medical PMA for what the company calls an enhanced Shockwave C2+ Coronary Intravascular Lithotripsy catheter.

latest-news-card-1
Federal Register

Regenerative Therapy Consensus Standards Guide

Federal Register notice: FDA releases a final guidance entitled Voluntary Consensus Standards Recognition Program for Regenerative Medicine Therapies;...

latest-news-card-1
Human Drugs

Pfizer Pentavalent Meningococcal Vaccine Approved

FDA approves Pfizers Penbraya (meningococcal groups A, B, C, W and Y vaccine), a pentavalent vaccine that protects against the most common serogroups ...

latest-news-card-1
Medical Devices

Philips Respironics Recalls V60 Ventilators

Philips Respironics recalls its V60 Ventilators and V60 Plus Ventilators because the devices contain power management printed circuit board assemblies...

latest-news-card-1
Medical Devices

Arrest Made in Misbranded Device Case

The U.S. government arrests a Chinese citizen related to a criminal complaint about manufacturing and distributing misbranded medical devices and maki...

latest-news-card-1
Human Drugs

BioMarin Expanded Indication for Voxzogo

FDA approves a BioMarin Pharmaceutical supplemental NDA for Voxzogo (vosoritide) to increase linear growth in pediatric patients with achondroplasia w...

latest-news-card-1
Federal Register

FDA Withdrawing 8 ANDAs

Federal Register notice: FDA withdraws approval of eight ANDAs after the applicants notified the agency that they were no longer marketed.